{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:33:37Z","timestamp":1790649217230,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    There is an urgent need to establish blood biomarkers for Alzheimer's disease (AD). Although it has been speculated that brain-derived neurotrophic factor (BDNF) is associated with AD, whether it can be used as a blood biomarker has yet to be determined. We used serum, cerebrospinal fluid (CSF), and medial temporal lobe atrophy from patients with AD to evaluate the association of BDNF with AD and assess its severity. For the blood analysis, 66 participants [21 normal controls (NCs) with normal cognitive function, 22 patients with mild cognitive impairment (MCI) due to AD, and 23 patients with AD] were included. For the CSF analysis, 30 participants were included. Magnetic resonance imaging, including a voxel-based specific regional analysis system for AD, and a Mini Mental State Examination were performed. Serum levels of BDNF and CSF levels of amyloid-\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    , total tau, and phosphorylated tau were measured using ELISA. Serum BDNF levels were significantly lower in the MCI due to AD group than in the NC group (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.037). Although there was no significant difference in the AD group, there was a downward trend compared to the NC group. Serum BDNF levels were positively correlated with CSF A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    levels (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.49,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.005). There was a significant correlation between serum BDNF levels and medial temporal lobe atrophy. Decreased serum BDNF can potentially be used as a biomarker for early AD detection. Early detection of AD with a less invasive blood test is very beneficial, as it allows for intervention before dementia progresses.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.653267","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T02:41:01Z","timestamp":1619145661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy"],"prefix":"10.3389","volume":"12","author":[{"given":"Yukiko","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyo","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Hieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuint.2017.08.010","article-title":"Alzheimer's disease as oligomeropathy","volume":"119","author":"Ono","year":"2018","journal-title":"Neurochem Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2018.03.006","article-title":"Blood biomarkers in Alzheimer's disease","author":"Altuna-Azkargota","year":"2018","journal-title":"Neurologia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0896-6273(90)90166-D","article-title":"Brain derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture","volume":"5","author":"Alderson","year":"1990","journal-title":"Neuron."},{"key":"B7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0166-2236(94)90138-4","article-title":"Role of neurotrophins in cholinergic neuron function in the adult and aged CNS","volume":"17","author":"Rylett","year":"1994","journal-title":"Trends Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","article-title":"Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease","volume":"76","author":"Holsinger","year":"2000","journal-title":"Brain Res Mol Brain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer's disease","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res Mol Brain Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","article-title":"BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease","volume":"7","author":"Phillips","year":"1991","journal-title":"Neuron."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3233\/JAD-190049","article-title":"Dysregulation of BDNF in prefrontal cortex in Alzheimer's disease","volume":"69","author":"Aarons","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00406-006-0652-8","article-title":"Serum BDNF, TNF-\u03b1 and IL-1\u03b2 levels in dementia patients: comparison between Alzheimer's disease and vascular dementia","volume":"256","author":"Yasutake","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-130497","article-title":"BDNF, TNF\u03b1, HSP90, CHF, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment","volume":"37","author":"Gezen-Ak","year":"2013","journal-title":"J Alzheimers Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.4088\/JCP.v69n0710","article-title":"Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han","volume":"69","author":"Yu","year":"2008","journal-title":"J Clin Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnagi.2014.00069","article-title":"A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly","volume":"6","author":"Shimada","year":"2013","journal-title":"Front Aging Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/ijms20020257","article-title":"Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer's disease (AD): a systematic review and meta-analysis","volume":"20","author":"Ng","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1007\/s12035-016-0192-9","article-title":"Peripheral brain derived neurotrophic factor levels in Alzheimer's disease and mild cognitive impairment: a comprehensive systematic review and meta-analysis","volume":"54","author":"Kim","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/mp.2016.62","article-title":"Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N = 7277)","volume":"22","author":"Qin","year":"2017","journal-title":"Mol Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1007\/s12035-017-0866-y","article-title":"Peripheral blood brain-derived neurotrophic factor as a biomarker of Alzheimer's disease: are there methodological biases?","volume":"55","author":"Balietti","year":"2018","journal-title":"Mol Neurobiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.arr.2016.01.003","article-title":"MRI morphometry in Alzheimer's disease","volume":"30","author":"Matsuda","year":"2016","journal-title":"Ageing Res Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.14336\/AD.2017.0818","article-title":"Voxel-based specific regional analysis system for Alzheimer's disease (VSRAD) on 3-tesla normal database: diagnostic accuracy in two independent cohorts with early Alzheimer's disease","volume":"9","author":"Sone","year":"2018","journal-title":"Aging Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D'Amato","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1113\/expphysiol.2009.048512","article-title":"Evidence for a release of brain-derived neurotrophic factor from the brain during exercise","volume":"94","author":"Rasmussen","year":"2009","journal-title":"Exp Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.arr.2012.01.007","article-title":"Evolutionary aspects of human exercise \u2013 born to run purposefully","volume":"11","author":"Mattson","year":"2012","journal-title":"Ageing Res Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1073\/pnas.1015950108","article-title":"Exercise training increases size of hippocampus and improves memory","volume":"108","author":"Erickson","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1523\/JNEUROSCI.6251-09.2010","article-title":"Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume","volume":"30","author":"Erickson","year":"2010","journal-title":"J Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000450601","article-title":"Brain-derived neurotrophic factor serum levels and hippocampal volume in mild cognitive impairment and dementia due to Alzheimer disease","volume":"6","author":"Borba","year":"2016","journal-title":"Dement Geriatr Cogn Dis Extra."},{"key":"B32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.653267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T02:41:03Z","timestamp":1619145663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.653267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":32,"alternative-id":["10.3389\/fneur.2021.653267"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.653267","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"article-number":"653267"}}